XLO·98422T209·US·equity-13D/G
XLO (XILIO THERAPEUTICS INC) is held by 8 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($483,516), RENAISSANCE TECHNOLOGIES LLC ($416,850), GEODE CAPITAL MANAGEMENT, LLC ($312,848). Net institutional sentiment: Bearish.
See how XLO's score breaks down across 4 SEC sources
Showing 1-20 of 20
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer